Anterogen Co (XKRX:065660) Beginning Cash Position : ₩1,389 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Beginning Cash Position?

Anterogen Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩1,389 Mil.

Anterogen Co's quarterly Beginning Cash Position declined from Sep. 2023 (₩2,931 Mil) to Dec. 2023 (₩2,139 Mil) and declined from Dec. 2023 (₩2,139 Mil) to Mar. 2024 (₩1,389 Mil).

Anterogen Co's annual Beginning Cash Position declined from Dec. 2021 (₩8,479 Mil) to Dec. 2022 (₩6,968 Mil) and declined from Dec. 2022 (₩6,968 Mil) to Dec. 2023 (₩3,903 Mil).

Anterogen Co Beginning Cash Position Historical Data

The historical data trend for Anterogen Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Beginning Cash Position Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

16,840.81

10,439.96

8,478.87

6,968.33

3,902.72

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															3,902.72	2,493.49	2,931.40	2,138.57	1,388.68

Anterogen Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Anterogen Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines